Since RCC patients frequently develop osteolytic bone metastases22 and many of them require orthopedic-oncological surgery for pathological or impending fractures, we examined whether serum sclerostin levels in RCC patients are different from healthy controls and whether osteolytic bone metastases are associated with higher sclerostin serum levels. Here, SOST is linked to renal cell carcinoma.